FORTIFY VR, U1.6 DF1 ID
Report
- Report Number
- 2938836-2019-05960
- Event Type
- Injury
- Date Received
- July 18, 2019
- Date of Event
- June 25, 2019
- Report Date
- October 21, 2019
- Manufacturer
- ABBOTT CRM
- Product Code
- LWS
- PMA / PMN Number
- P910023
- Removal / Correction Number
- Z-0003-2018; Z-0115-2017
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PL
- Reporter Occupation
- PHYSICIAN
Narratives
THE INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT.
PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. A DEVICE EVALUATION WAS PERFORMED, AND NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.
FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 597118 | FORTIFY VR, U1.6 DF1 ID | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | ABBOTT CRM | CD1233-40 | 4221441 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R |